Study in Healthy Adults Evaluating PF-07202954
Completed · Phase 1 · Has a placebo group
Conditions studied: Non-Alcoholic Fatty Liver Disease, Liver Fibrosis
In brief
The study is planned as a 3 part design with investigator and participant blinded (sponsor-open), placebo controlled, randomized, dose escalation in Part 1 and Part 2; and a randomized, open label design, in Part 3 (if conducted).
Key facts
- Study ID
- NCT04857437
- Run by
- Pfizer
- People needed
- 12
- Starts
- 2021-05-13
- Expected to finish
- 2021-09-17
- Last updated by the study team
- 2024-09-20
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- New Haven Clinical Research Unit — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.